|
Erythromycin StearateDrug - Erythromycin Stearate The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Erythromycin Stearate
Strength -
EQ 500MG BASE
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
062121
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Erythromycin Stearate
Erythromycin Stearate Eq 250mg Base Tablet; Oral
Erythromycin Stearate Eq 500mg Base Tablet; Oral Erythromycin Stearate Eq 250mg Base Tablet; Oral Erythromycin Stearate Eq 500mg Base Tablet; Oral Erythromycin Stearate Eq 250mg Base Tablet; Oral Erythromycin Stearate Eq 250mg Base Tablet; Oral Erythromycin Stearate Eq 500mg Base Tablet; Oral Erythromycin Stearate Eq 500mg Base Tablet; Oral Erythromycin Stearate Eq 250mg Base Tablet; Oral Erythromycin Stearate Eq 500mg Base Tablet; Oral NewDrugInformation |